The PROSVIDA Association has issued a warning about the risks of prolonged treatments for prostatitis. After analyzing a severe case, the organization points out that many extensive therapies are applied without a definitive diagnosis, masking more serious conditions such as prostate cancer. The affected patient received months of antibiotics and anti-inflammatories while a tumor grew undetected.
AI Diagnosis and Biomarkers: The New Standard in Urology 🩺
Current technology allows overcoming these diagnostic shortcomings. Artificial intelligence systems analyze multiparametric MRIs with high precision, differentiating prostatic inflammation from malignant lesions. Biomarkers such as isoform PSA and the Prostate Health Index (PHI) provide objective data before starting therapies. These methods reduce false indications for long treatments and allow patients to receive specific care in early stages. Integrating these tools into clinical practice is key to avoiding late diagnoses.
The Doctor Who Prescribed Antibiotics Until the Patient Said Enough 💊
It seems some specialists rely more on persistence than on tests. Prescribing months of antibiotics without a clear diagnosis is like pouring gasoline into a car that won't start: maybe the problem isn't the fuel. The patient in this case lived with discomfort for months, spent money on pharmacy bills, and almost ran out of time for cancer treatment. Good thing the prostate has no voice, because if it could speak, it would have asked for a second opinion much sooner.